Management of Moderate Cystic Acne

First‑Line Systemic Therapy

Oral doxycycline 100 mg once daily is the strongly recommended first‑line oral antibiotic for moderate cystic acne, supported by moderate‑certainty evidence. 1
Minocycline 100 mg once daily may be used as a conditional second‑line alternative when doxycycline is not tolerated. 1
Oral antibiotics must be combined with topical therapy; monotherapy is prohibited because it rapidly induces bacterial resistance. 1

All patients should receive a concurrent fixed‑dose combination of adapalene 0.1‑0.3 % plus benzoyl peroxide 2.5‑5 % applied once daily in the evening to address comedones, micro‑comedones, and provide antimicrobial activity. 1
An alternative or adjunctive topical option is a fixed‑dose clindamycin 1 %/benzoyl peroxide 5 % formulation for additional inflammatory control. 1

Intralesional triamcinolone acetonide injected into individual large, painful cystic nodules yields rapid pain relief and inflammation reduction within 48‑72 hours. 1
Use low concentrations (2.5‑10 mg/mL) and minimal injection volumes to minimize the risk of skin atrophy. 1

Systemic antibiotics should be limited to a maximum of 3‑4 months to minimize the development of bacterial resistance. 1
Extending oral antibiotic therapy beyond this period without re‑evaluation markedly increases resistance risk and antibiotic‑associated complications. 1

Initiate isotretinoin if moderate cystic acne does not respond after 3‑4 months of appropriate triple therapy (oral antibiotic + topical retinoid + benzoyl peroxide). 1
Additional indications for isotretinoin include:

In females with hormonal patterns (e.g., premenstrual flares, jaw‑line distribution), add spironolactone 25‑200 mg daily or a combined oral contraceptive to the regimen. 1
Spironolactone does not require routine potassium monitoring in healthy patients without risk factors for hyperkalemia. 1

Never use topical or oral antibiotics without concurrent benzoyl peroxide, as resistance develops rapidly. 1
Do not extend oral antibiotic courses beyond 3‑4 months without re‑evaluation; doing so dramatically raises resistance risk and complication rates. 1
Any evidence of scarring should prompt consideration of isotretinoin, irrespective of lesion count. 1
Oral antibiotics alone are insufficient for severe cystic/nodular acne and may delay definitive isotretinoin therapy. 1